Here are the top-15 most read blog posts (as determined by WordPress 11 July 2018), and some of my favorite blog posts (from 2015-present), respectively:
- A Comparison of Parkinson’s to Alzheimer’s.
- Meditation, Yoga, and Exercise in Parkinson’s.
- 9 Things to Know About Exercise-induced Neuroplasticity in Human Parkinson’s.
- Isradipine: Shutting the Door on Calcium Channels to Slow the Progression of Parkinson’s.
- The Alpha-Synuclein Story In Parkinson’s.
- Dopamine: A Symbol of Hope.
- Parkinson’s Awareness Month: Quotes About Parkinson’s Disease.
- Golf And Parkinson’s: A Game For Life.
- The Yack on NAC (N-Acetyl-Cysteine) and Parkinson’s.
- B Vitamins (Folate, B6, B12) Reduce Homocysteine Levels Produced by Carbidopa/Levodopa Therapy.
- Happiness and Parkinson’s: 10 Simple Suggestions to Make Your Life Happier.
- Believe In Big Movements Of LSVT BIG Physical Therapy For Parkinson’s.
- Poetry to Parkinson’s.
- Potential New Parkinson’s Drug Highlight: the Leukemia Drug Nilotinib.
- Complementary and Alternative Medicine (CAM) and Over-the-Counter Therapies in Parkinson’s.
2018- Four Favorites of Frank (So Far):
- Planet Patient vs Planet Researcher: From Both Sides, Now
- Understanding The Positive Health Benefits of Gratitude
- Parkinson’s Awareness Month: The Science Behind How Exercise Slows Disease Progression
- Neuroprotection with Taurine in a Parkinson’s Model System
2017- Four Favorites of Frank:
- The Mask of Parkinson’s
- 200 Years Ago James Parkinson published “An Essay On The Shaking Palsy”
- Milestones in Parkinson’s Disease Research and Discovery
- Building Empathy for Parkinson’s
2016- Four Favorites of Frank:
- Déjà Vu and Neuroplasticity in Parkinson’s
- 7 Healthy Habits For Your Brain
- Believe in Life in the Presence of Parkinson’s
- Treatment of Parkinson’s Psychosis with Nuplazid
2015- Four Favorites of Frank:
- Purple Haze of Parkinson’s: How Dopamine Works.
- How Do You Feel When You Wake Up Each Morning?
- Hope Resides Within the Adversity of Parkinson’s
- Leucine-rich Repeat Kinase 2 (LRRK2) Is A Possible Target For Therapy In Parkinson’s
Cover Photo Credit: Frank C. Church